
Conformis CFMS
Conformis DPO | CFMS
DPO Jährlich Conformis
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 50.4 | 61.3 | 61.6 | 46.5 | 36.8 | 38.4 | 35 | 33.7 | 20.4 | - | - | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 61.6 | 20.4 | 42.7 |
DPO Vierteljährlich Conformis
| 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 31.6 | 49.1 | - | 70.2 | 57.2 | 54.5 | - | 55.8 | 51.6 | 59.1 | - | 64.1 | 68.2 | 64.6 | - | 41.4 | 39.5 | 33.3 | - | 51.5 | 47.4 | 39 | - | 38.6 | 40.4 | 36.7 | - | 23.9 | 27.2 | 36.1 | - | 45.8 | 39.5 | 40.5 | - | 44.9 | 23.3 | - | - | - | - | - | - | - | - | - | - | - | - | - |
Alle Zahlen in USD-Währung
Indikatorspanne aus vierteljährlicher Berichterstattung
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 70.2 | 23.3 | 45.5 |
DPO anderer Aktien in der Medizinische Geräte
| Name | DPO | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Cutera
CUTR
|
57.2 | - | -10.19 % | $ 1.99 M | ||
|
EDAP TMS S.A.
EDAP
|
116 | - | - | $ 162 M | ||
|
GenMark Diagnostics, Inc.
GNMK
|
81.3 | - | - | $ 1.77 B | ||
|
Avinger
AVGR
|
45.5 | - | -20.74 % | $ 369 K | ||
|
Axonics Modulation Technologies
AXNX
|
54.7 | - | - | $ 3.31 B | ||
|
Eargo
EAR
|
124 | - | - | $ 10.2 M | ||
|
Lianluo Smart Limited
LLIT
|
10.5 | - | 24.59 % | $ 44.8 M | ||
|
LENSAR
LNSR
|
146 | $ 5.6 | -2.78 % | $ 67 M | ||
|
Allied Healthcare Products
AHPI
|
23.1 | - | 3.58 % | $ 2.21 M | ||
|
Obalon Therapeutics, Inc.
OBLN
|
224 | - | -5.86 % | $ 30.6 M | ||
|
Apollo Endosurgery
APEN
|
63.6 | - | - | $ 475 M | ||
|
Aziyo Biologics
AZYO
|
286 | - | 1.37 % | $ 20.5 M | ||
|
BIOLASE
BIOL
|
66.7 | - | -13.19 % | $ 166 K | ||
|
Outset Medical
OM
|
11.1 | $ 4.04 | -4.49 % | $ 61.5 K | ||
|
AxoGen
AXGN
|
34.4 | $ 39.49 | -0.6 % | $ 1.82 B | ||
|
Insulet Corporation
PODD
|
22.5 | $ 163.26 | 3.08 % | $ 11.5 B | ||
|
Cardiovascular Systems
CSII
|
81.8 | - | 0.15 % | $ 844 M | ||
|
Quanterix Corporation
QTRX
|
50.7 | $ 3.67 | -6.38 % | $ 156 M | ||
|
CryoLife, Inc.
CRY
|
41.1 | - | -4.14 % | $ 702 M | ||
|
Bruker Corporation
BRKR
|
44.2 | $ 60.45 | -2.74 % | $ 9.18 B | ||
|
CHF Solutions, Inc.
CHFS
|
204 | - | 1.15 % | $ 34.5 M | ||
|
Sintx Technologies
SINT
|
223 | $ 1.42 | -6.58 % | $ 3.94 M | ||
|
Itamar Medical Ltd.
ITMR
|
131 | - | 0.03 % | $ 1.58 B | ||
|
Misonix, Inc.
MSON
|
83.1 | - | - | $ 462 M | ||
|
TELA Bio
TELA
|
31.8 | $ 0.69 | -2.81 % | $ 32.4 M | ||
|
Neovasc
NVCN
|
48.6 | - | - | $ 111 M | ||
|
Dynatronics Corporation
DYNT
|
52.2 | - | 14.99 % | $ 929 K | ||
|
Tactile Systems Technology
TCMD
|
24.4 | $ 27.48 | 0.15 % | $ 629 M | ||
|
TransMedics Group
TMDX
|
15.5 | $ 72.26 | 1.59 % | $ 2.46 B | ||
|
IRIDEX Corporation
IRIX
|
29.4 | $ 0.89 | -3.38 % | $ 15.1 M | ||
|
Tandem Diabetes Care
TNDM
|
35.7 | $ 17.12 | 1.3 % | $ 1.16 B | ||
|
Intersect ENT, Inc.
XENT
|
72.8 | - | - | $ 955 M | ||
|
Second Sight Medical Products
EYES
|
29.6 | - | -0.97 % | $ 54.4 M | ||
|
GBS
GBS
|
319 | - | -0.57 % | $ 7.12 M | ||
|
ClearPoint Neuro
CLPT
|
33.2 | $ 14.12 | -2.55 % | $ 400 M | ||
|
Viemed Healthcare
VMD
|
20.1 | $ 11.77 | 0.86 % | $ 458 M | ||
|
Avanos Medical
AVNS
|
57.7 | $ 24.99 | 0.04 % | $ 1.16 B | ||
|
Beyond Air
XAIR
|
107 | $ 5.16 | -5.67 % | $ 42.8 B | ||
|
Invacare Corporation
IVC
|
75.6 | - | - | $ 24.7 M | ||
|
Xtant Medical Holdings
XTNT
|
43.2 | $ 0.43 | -0.39 % | $ 60 M | ||
|
Cytosorbents Corporation
CTSO
|
107 | $ 0.36 | -0.39 % | $ 22.4 M | ||
|
NanoVibronix
NAOV
|
58.2 | - | - | $ 1.08 M | ||
|
NuVasive
NUVA
|
19.8 | - | - | $ 2.07 B | ||
|
Natus Medical Incorporated
NTUS
|
52.1 | - | 1.94 % | $ 1.05 B | ||
|
Nevro Corp.
NVRO
|
61.7 | - | - | $ 217 M | ||
|
Inogen
INGN
|
34.6 | $ 6.15 | -2.69 % | $ 164 M |